Toulmin, S. A., Bhadiadra, C., Paris, A. J., Lin, J. H., Katzen, J., Basil, M. C., . . . Eisenlohr, L. C. (2021). Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation. Nature Portfolio.
Style de citation Chicago (17e éd.)Toulmin, Sushila A., Chaitali Bhadiadra, Andrew J. Paris, Jeffrey H. Lin, Jeremy Katzen, Maria C. Basil, Edward E. Morrisey, G. Scott Worthen, et Laurence C. Eisenlohr. Type II Alveolar Cell MHCII Improves Respiratory Viral Disease Outcomes While Exhibiting Limited Antigen Presentation. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Toulmin, Sushila A., et al. Type II Alveolar Cell MHCII Improves Respiratory Viral Disease Outcomes While Exhibiting Limited Antigen Presentation. Nature Portfolio, 2021.